Financial News
Veracyte Inc (NQ: VCYT )
23.46
+0.29
(+1.23%)
Streaming Delayed Price
Updated: 11:24 AM EDT, Jul 22, 2024
Add to My Watchlist
All News about Veracyte Inc
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_146.jpeg?width=720)
![](https://cdn.pixabay.com/photo/2020/03/25/11/34/syringe-4966959__340.jpg)
![](https://mms.businesswire.com/media/20210823005429/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_285.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1911.png)
![](https://mms.businesswire.com/media/20210803005482/en/895816/5/Veracyte_Logo_Registered_Mark_Vertical_for_Press_Releases_Aug_2021.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_256.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210729006048/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Second Quarter 2021 Financial Results
July 29, 2021
From Veracyte, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884775_1920_81.jpg)
![](https://g.foolcdn.com/editorial/images/633758/dna-sequence-genetics-test-genomics.jpg)
![](https://mms.businesswire.com/media/20210727006066/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20210712005237/en/890622/5/Rebecca_Chambers_Photo_7-21.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/national-cancer-institute-xknubmnjbkg-unsplash_0.jpg)
![](https://mms.businesswire.com/media/20210708005868/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20210708005329/en/890157/5/Bill_Zondler_headshot_6-21.jpg)
![](https://images.pexels.com/photos/4033021/pexels-photo-4033021.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://mms.businesswire.com/media/20210701005296/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210614005271/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210604005373/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20210602005933/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20210602005933/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte to Present at Upcoming Investor Conferences
June 02, 2021
From Veracyte, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_528.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.